Table 1

Clinical characteristics of neonates treated with ranitidine

Gestational weeks	Birthweight (g)	Diagnosis	Reason for ranitidine treatment	Dose of ranitidine (mg/kg body weight)
30	1135	Prematurity	Concomitant with corticosteroids	0.5
31	1750	Prematurity	Melena	0.5
33	3000	Omphalocele	Concomitant with indomethacin	0.5
39	3280	Gastroschisis	Bloody nasogastric secretion	0.5
42	4360	Asphyxia	Haematemesis	0.5
29	1000	Prematurity	Concomitant with indomethacin	1.0
33	3000	Duodenal atresia	Bloody nasogastric secretion	1.0
35	2440	Prematurity	Concomitant with indomethacin	1.0
35	2470	Gastroschisis	Haematemesis	1.0
39	2750	Meconium aspiration	Gross blood in stools	1.0
40	3300	Asphyxia	Haematemesis	1.0
28	1140	Prematurity	Concomitant with corticosteroids	1.5
31	2000	Prematurity	Concomitant with indomethacin	1.5
38	3330	Asphyxia	Haematemesis	1.5
38	3300	Eating disturbances	Haemorrhagic gastritis	1.5
39	4300	Persistent pulmonary hypertension	Haematemesis	1.5